Evidence map›Paper›PMID 34996942›Full record

ArticleScientific reports2022

Decrease of Pdzrn3 is required for heart maturation and protects against heart failure.

Mathieu Pernot, Béatrice Jaspard-Vinassa, Alice Abelanet, Sebastien Rubin, Isabelle Forfar, Sylvie Jeanningros, Laura Cetran, Murielle Han-Yee Yu, Elise Balse, Stéphane Hatem and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Mathieu PernotUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Béatrice Jaspard-Vinassa *Univ. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Alice Abelanet *Univ. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Sebastien RubinUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Isabelle ForfarUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Sylvie JeanningrosUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Laura CetranUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Murielle Han-Yee YuUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Elise BalseFaculté de Médecine, Université Pierre et Marie Curie, Sorbonne University, INSERM UMR_S1166, Paris, France.
Stéphane HatemFaculté de Médecine, Université Pierre et Marie Curie, Sorbonne University, INSERM UMR_S1166, Paris, France.
Pascale DufourcqUniv. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Thierry Couffinhal *Univ. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Cécile Duplàa *Univ. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France. cecile.duplaa@inserm.fr.
Biologie des maladies cardiovasculairesInserm · FRUniversité de Bordeaux · FRSorbonne Université · FR

Funding

Agence National de la Recherche ANR -16-CE17-0001-01 ANR -16-CE17-0001-01
6 · The paper itself

Abstract

Heart failure is the final common stage of most cardiopathies. Cardiomyocytes (CM) connect with others via their extremities by intercalated disk protein complexes. This planar and directional organization of myocytes is crucial for mechanical coupling and anisotropic conduction of the electric signal in the heart. One of the hallmarks of heart failure is alterations in the contact sites between CM. Yet no factor on its own is known to coordinate CM polarized organization. We have previously shown that PDZRN3, an ubiquitine ligase E3 expressed in various tissues including the heart, mediates a branch of the Planar cell polarity (PCP) signaling involved in tissue patterning, instructing cell polarity and cell polar organization within a tissue. PDZRN3 is expressed in the embryonic mouse heart then its expression dropped significantly postnatally corresponding with heart maturation and CM polarized elongation. A moderate CM overexpression of Pdzrn3 (Pdzrn3 OE) during the first week of life, induced a severe eccentric hypertrophic phenotype with heart failure. In models of pressure-overload stress heart failure, CM-specific Pdzrn3 knockout showed complete protection against degradation of heart function. We reported that Pdzrn3 signaling induced PKC ζ expression, c-Jun nuclear translocation and a reduced nuclear ß catenin level, consistent markers of the planar non-canonical Wnt signaling in CM. We then show that subcellular localization (intercalated disk) of junction proteins as Cx43, ZO1 and Desmoglein 2 was altered in Pdzrn3 OE mice, which provides a molecular explanation for impaired CM polarization in these mice. Our results reveal a novel signaling pathway that controls a genetic program essential for heart maturation and maintenance of overall geometry, as well as the contractile function of CM, and implicates PDZRN3 as a potential therapeutic target for the prevention of human heart failure.

Indexed as

Animalsbeta CateninHeartHeart FailureHumansMaleMiceMice, KnockoutMyocytes, CardiacProtein Kinase CSignal TransductionUbiquitin-Protein Ligasesbeta CateninPDZRN3 protein, mouseProtein Kinase CUbiquitin-Protein Ligases

Identifiers

PMID34996942
PMCPMC8742099
OpenAlexW4206259189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.